Published online Feb 7, 2014. doi: 10.3748/wjg.v20.i5.1305
Revised: October 16, 2013
Accepted: November 1, 2013
Published online: February 7, 2014
Processing time: 163 Days and 22.5 Hours
AIM: To evaluate the expression of Bcl-xL, Bak, and Bax proteins in correlation with particular clinico-histopathological parameters, including tumor invasion front, in patients with colorectal cancer.
METHODS: The expression of these proteins was evaluated with the use of the immunohistochemical method in 50 primary tumors.
RESULTS: According to observations, a low expression of Bax and Bak proteins is related to the localization of the tumor in the rectum (P < 0.05 and P < 0.05 respectively), which may explain an increased incidence of colorectal cancer in this area. A positive expression of Bax protein also correlates with the presence of cancer cell infiltration to lymph and blood vessels (P < 0.05), which may suggest the participation of this protein in the early stages of colorectal cancer progression. Moreover, a positive expression of Bcl-xL protein correlated with a positive expression of Bak protein. This may suggest a greater participation of Bcl-xL protein in the inhibition of the proapoptotic Bak protein, but not the Bax protein.
CONCLUSION: Bax protein is probably very significant in the cancerogenesis mechanism in the large intestine.
Core tip: We determined the expressions of Bax, Bak, and Bcl-xL proteins in colorectal cancer tissue. We reported that low expression of Bax and Bak proteins is related to the localization of the tumor in the rectum, which may explain an increased incidence of colorectal cancer in this area. We also presented the participation of Bax protein in the early stages of colorectal cancer progression. Moreover, our results suggest a greater participation of Bcl-xL protein in the inhibition of the proapoptotic Bak protein, but not the Bax protein. Therefore, Bax protein is probably very significant in the carcinogenesis mechanism in the large intestine.